ABPI names Haseeb Ahmad as President

ABPI names Haseeb Ahmad as President

The ABPI names Haseeb Ahmad as President. Haseeb Ahmad, Managing Director, UK, Ireland & Nordics Novartis Pharmaceuticals and Country President Novartis UK has been confirmed...
new migraine data for Aimovig presented by Novartis

Novartis presents new migraine data for Aimovig®▼ (erenumab)

Novartis presents new migraine data for Aimovig®▼ (erenumab) demonstrating sustained efficacy to 52 weeks. Novartis has announced that new data from two follow-up studies of...
AMAL Therapeutics enters into a collaborative agreement with Boehringer Ingelheim

AMAL Therapeutics enters clinical collaboration with Boehringer Ingelheim

AMAL Therapeutics (AMAL), a Swiss biotech developing novel, peptide-based therapeutic cancer vaccines, has entered into a collaborative agreement with Boehringer Ingelheim. AMAL will conduct an...
Most promising treatments will be fast-tracked by the new Accelerated Access Collaborative

ABPI responds to Accelerated Access Collaborative announcement

The UK Government is to announce at the ABPI Conference that the most promising treatments will be fast-tracked by the new and boosted Accelerated...
Sandoz enters agreement for proposed trastuzumab biosimilar

Sandoz enters agreement for proposed trastuzumab biosimilar

Sandoz enters agreement for proposed trastuzumab biosimilar, currently in Phase III development, to treat selected HER2-positive cancer tumors. Sandoz, a Novartis division, has announced that...
New Drug Application for injectable HIV treatment

ViiV Healthcare submit New Drug Application for injectable HIV treatment

ViiV Healthcare has submitted a New Drug Application to the FDA for the monthly injectable HIV treatment, a two-drug regimen of cabotegravir and rilpivirine.  ViiV Healthcare,...
The FDA approval of Praluent ® (alirocumab)

FDA approval of Praluent ® to prevent heart attack, stroke & unstable angina

The FDA approval of Praluent ® (alirocumab) to reduce the risk of heart attack, stroke, and unstable angina requiring hospitalisation.  The U.S. Food and Drug Administration...
The UK Space Agency and Science Minister have announced the use of space technology to fight bowel cancer and exposure to air pollution. The new health technologies inspired by working in space will provide real-time diagnosis of bowel cancer and freedom from air pollution

Space technology to fight bowel cancer and exposure to air pollution

The UK Space Agency and Science Minister have announced the use of space technology to fight bowel cancer and exposure to air pollution. The...
Roche test aids clinicians in accelerating tuberculosis diagnosis and treatment

Medicines Discovery Catapult partners with UK contract research organisations

Medicines Discovery Catapult partners with UK contract research organisations (CROs) leveraging the UK’s renowned contract research sector to boost industrial growth. Medicines Discovery Catapult has...
behaviour change on the frontline of pharma

Collaboration to develop potential new pain medicines

LifeArc® has signed a deal with The University of Kent to develop potential new pain medicines. They will collaborate on an ion channel drug discovery...

Latest articles

GSK has announced changes to its sales representative incentive programme for representatives in certain countries

Changes to GSK sales representative incentive programme

GSK has announced changes to its sales representative incentive programme for representatives in certain countries. These changes reflect the growing shift in GSK’s portfolio...
UK's first free mental health app has gone live

Peer-to-peer mental health support app goes live

The UK's first free peer-to-peer mental health support app, 'Unmasked', has gone live after a period of extensive testing. The brainchild of three Yorkshiremen, Logan...
illegal market sharing over anti-nausea tablets

Drug firms accused of illegal market sharing over anti-nausea tablets

The Competitions and Markets Authority (CMA) has accused four pharmaceutical companies of illegal market sharing over anti-nausea tablets. The CMA has provisionally found that the pharmaceutical...

Popular articles

UK's first free mental health app has gone live

Peer-to-peer mental health support app goes live

The UK's first free peer-to-peer mental health support app, 'Unmasked', has gone live after a period of extensive testing. The brainchild of three Yorkshiremen, Logan...
NICE issues final guidance for Tegsedi ®▼

NICE issues final guidance for Tegsedi ®▼

Akcea Therapeutics UK Ltd, an affiliate of Akcea Therapeutics, Inc announced that the National Institute for Health and Care Excellence (NICE) has published its...
pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
GSK has announced changes to its sales representative incentive programme for representatives in certain countries

Changes to GSK sales representative incentive programme

GSK has announced changes to its sales representative incentive programme for representatives in certain countries. These changes reflect the growing shift in GSK’s portfolio...
Wasdell Group announces acquisition of Honeywood Limited

Wasdell Group expands portfolio with Honeywood acquisition

The Wasdell Group (Wasdell), a leading outsourcing partner for companies in the pharmaceutical industry, has announced its acquisition of Honeywood Limited, a specialist manufacturer...